CHRONIC DISEASE MANAGEMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Global chronic disease management market is estimated to be valued at USD 5.71 Bn in 2024 and is expected to reach USD 13.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.
Discover market dynamics shaping the industry request sample copy
Due to rising geriatric population worldwide and growing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer, there has been increase in need for effective chronic disease management solutions. Various market players are focusing on development of innovative digital health solutions such as remote patient monitoring services and healthcare apps to facilitate efficient chronic disease management. This can boost adoption of chronic disease management services and solutions. Furthermore, increasing healthcare costs associated with treatment of chronic diseases prompt government agencies and private insurance players to promote effective chronic disease management programs. This can provide growth opportunities for chronic disease management market during the forecast period.
Market Driver - Increasing prevalence of chronic diseases
As longevity increases worldwide and lifestyles become more sedentary, chronic diseases have emerged as the major public health concern. Chronic diseases such as diabetes, cardiovascular disease, cancer, and respiratory diseases are long-lasting health conditions that require ongoing management over several years. These diseases generally cannot be prevented entirely but their progression can be slowed down and their impact minimized through timely diagnosis and treatment.
Chronic diseases account for a large and growing share of disease burden across both developed and developing nations. For instance, heart disease, stroke, and diabetes collectively account for over 75% of U.S. healthcare spending according to recent studies. Rates of obesity, hypertension and metabolic disorders such as diabetes have surged among middle-aged groups in developing countries experiencing rapid urbanization and lifestyle changes. According to the data published by World Health Organization, chronic diseases accounted for almost three-quarters of all deaths worldwide by 2020. The elderly population, who often suffer from multiple chronic conditions simultaneously, has been growing rapidly in both developed and emerging economies.
This exponential rise in chronic ailments has put immense pressure on global healthcare systems. This growing emphasis on chronic disease management as a healthcare approach can offer growth opportunities for related technologies, services and solutions. For instance, in April 2021, WellSky introduced an advanced home health visit management solution called Care Insights Guidance. This new feature provides actionable insights on visit utilization, aimed at balancing the quality of treatment with improvements in patient health. The launch of this solution is anticipated to benefit both patients and employees.
Get actionable strategies to beat competition: Get instant access to report
Technological advancements
This digital transformation enable innovative approaches for managing chronic conditions. Remote monitoring devices, digital therapies, AI platforms and telehealth enables early detection, personalized care and better self-management of diseases outside traditional clinical settings.
Wearables and wireless patient devices have made remote monitoring highly convenient. Smart watches, activity trackers, glucose meters, and others automatically capture vital signs, nutrition intake and medication adherence data on a daily basis at home. This constant stream of health metrics allows timely interventions even when physiological changes occur between doctor visits. Technologies like predictive analytics and machine learning can analyze these data patterns to detect anomalies, exacerbations and risks early on as these escalate into medical emergencies. AI assistance also help clinicians to make more informed treatment decisions through simulation modeling and diagnostic support.
Telehealth platforms powered by digital connectivity can expand access to care, particularly in rural communities. Virtual visits, video consultations, and Chabot assistants facilitate communication between patients and multidisciplinary care teams without the need for in-person visits. Digital therapeutics in the form of mobile apps, websites, and serious games can guide behavior change through personalized nudges, interactive lessons and gaming mechanics to foster health literacy and self-care skills. Such virtual approaches especially benefit patients with mobility issues or requiring long-term follow ups for their condition management.
This proliferation of digital tools can revolutionize chronic disease monitoring from reactive to proactive. Technological advancements enables a paradigm shift towards preventive, patient-centric and value-based models of managing chronic illnesses more holistically across healthcare ecosystems. This evolution towards ubiquitous connected care technologies and experiences can boost the global chronic disease management market growth.
Key Takeaways from Analyst:
Global chronic disease management market growth is driven by rising geriatric population worldwide and increasing prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. However, lack of healthcare infrastructure and awareness in developing nations can hamper the market growth. The market witness opportunities due to increasing adoption of digital health solutions for chronic disease management.
North America currently dominates the market due to supportive government initiatives and well-established healthcare infrastructure. However, Asia Pacific region is poised to be the fastest growing regional market due to improving economic conditions, increasing healthcare investments, rising medical tourism, and growing patient awareness in developing countries such as China and India.
On the basis of service type, disease management program segment dominates the market. However, technology management services segment is likely to witness the highest growth rate owing to rising penetration of digital technologies and wearable devices for remote monitoring of chronic conditions. Growing focus of market players on patient-centric care and preventive healthcare can drive the chronic disease management growth during the forecast period.
Market Challenge - High costs of management programs
Global chronic disease management market growth can be hampered due to high costs associated with managing chronic diseases through specialized programs. As global prevalence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases increases, more patients require lifelong treatment and monitoring to manage their conditions effectively. However, setting up chronic disease management programs entails significant upfront investments in specialized equipment, training of healthcare professionals, and developing customized care plans for each patient. Moreover, actual treatment and ongoing care of patients enrolled in such programs leads to higher recurring operational expenses. With rising healthcare costs worldwide, it is challenging for governments, insurance providers, and patients to bear the financial burden of comprehensive chronic disease management programs over extended periods of time. This acts as a barrier to broader adoption of evidence-based chronic illness management practices, especially in low and middle-income countries.
Opportunity- Expansion of telehealth services
Global chronic disease management market players can witness growth opportunities due to expansion of telehealth and remote patient monitoring services. With advancements in digital health technologies, it is possible to remotely track patient vitals, symptoms, medication adherence and conduct remote consultations using tools like connected devices, mobile apps and video conferencing solutions. The use of telehealth offers improved access to healthcare without the need for in-person visits while also reducing costs for patients and providers. As patients seek more convenient care options to better manage chronic diseases from the comfort of their homes, there will be huge demand for telehealth. Market analysts predict telehealth could account for over 30% of the chronic disease management market by 2030. Leading healthcare organizations and technology companies are heavily investing in innovative virtual care solutions and remote patient monitoring platforms to tap into this promising opportunity.
Discover high revenue pocket segments and roadmap to it: Get instant access to report
By Disease Type - Ageing population drives cardiovascular disease segment
In terms of disease type, cardiovascular diseases segment is estimated to contribute the highest market share of 30.1% in 2024, owing to growing elderly population globally. As people age, these become more susceptible to cardiovascular issues such as heart disease, heart attacks and strokes. Advancing age is one of the major unmodifiable risk factors for such chronic conditions. With improved healthcare and lifestyle standards worldwide, life expectancy has been increased over the past few decades. This has resulted in growing pool of elderly individuals prone to cardiovascular ailments. According to estimates, cardiovascular diseases account for over 17 million deaths per year globally. This number is projected to increase further with rapidly ageing population. Chronic disease management programs and remote monitoring solutions are crucial to manage the cardiovascular healthcare needs of senior citizens and help curb mortality rates from such conditions.
By Service Type - Need for better disease management drives disease management programs segment
In terms of service type, disease management programs segment is estimated to contribute the highest market share of 34.2% in 2024, owing to need for more structured care of chronic diseases. As newer healthcare delivery models focus on preventive care and population health, traditional uncoordinated treatment of long-term conditions has proven insufficient. These multi-disciplinary programs aim to enhance outcomes through comprehensive medical and lifestyle intervention. These employ evidence-based guidelines, physician-directed care plans and patient education resources to ensure safer and more effective management of chronic diseases across settings and over time. The success of disease management approaches in cutting costs and healthcare utilization has prompted greater uptake among payers, providers as well as patients.
By Delivery Mode - Efficiency and cost benefits drive on-premise deployment segment
In terms of delivery mode, on-premise segment is estimated to contribute the highest market share of 48.2% in 2024, owing to efficiency and security advantages it offers to large healthcare organizations. While cloud-based and web-based solutions enable flexibility, their dependence on reliable high-speed internet could pose challenges in implementation across diverse geographic locations. Healthcare providers with substantial resources prefer having dedicated servers and IT support for chronic disease management programs and services. This allows them to retain complete control over sensitive patient data and optimize performance as per own infrastructure capabilities. It also eliminates monthly subscription costs in the long-run. Large provider networks and integrated delivery systems especially favor on-premise deployment for synchronized multi-facility operations. Thus, on-premise model continues to be the preferred choice where upfront capital investments are not a constraint due to anticipated performance and cost-effectiveness over time.
To learn more about this report, request sample copy
North America dominates the global chronic disease management market, with an estimated market share of 40.3% in 2024, due to high healthcare expenditure and well-developed insurance and reimbursement structure in the region. The U.S. accounts for the major share due to growing prevalence of chronic diseases in the country. It has been estimated that nearly half of all American adults suffer from at least one chronic medical condition. This has prompted proactive health monitoring to manage diseases effectively. The region is home to leading medical technology companies offering advanced devices and solutions for chronic disease management. The availability of innovative products along with provision for insurance coverage has encouraged greater adoption of digital health services in the outpatient as well as home settings.
The Latin America region is emerging as the fastest-growing market for chronic disease management due to several key factors. Increasing urbanization and lifestyle changes have led to a rise in chronic conditions such as diabetes, hypertension, and cardiovascular diseases. Additionally, there is a growing awareness of the importance of preventive care and disease management, coupled with improved access to healthcare services and technologies. Government initiatives to enhance healthcare infrastructure and promote telehealth solutions further contribute to this growth. The combination of these elements presents significant opportunities for healthcare providers and technology companies in the region, driving the expansion of chronic disease management solutions.
Chronic Disease Management Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 5.71 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 13.4% | 2031 Value Projection: | US$ 13.80 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
UnitedHealth Group, CVS Health, Cigna, Anthem, Inc., Aetna (a CVS Health company), Mayo Clinic, Kaiser Permanente, Humana Inc., Teladoc Health, Inc., McKesson Corporation, Cerner Corporation, Epic Systems Corporation, Medtronic, Abbott Laboratories, Novartis AG, Roche Holding AG, Bristol-Myers Squibb, Johns Hopkins Medicine, GE Healthcare, and Philips Healthcare |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: Global chronic disease management market consists of products and services aimed at effectively managing chronic diseases and improving patient outcomes. This includes remote patient monitoring devices, digital health solutions like mobile health apps, healthcare provider services for disease diagnosis, treatment, and ongoing care, as well as activities related to increasing patient adherence to treatment plans and providing lifestyle and behavior change programs for disease prevention and health management.
Share
About Author
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Credibility and Certifications
860519526
9001:2015
27001:2022
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowSelect a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
